XT
CMMB

XTX Topco’s Chemomab Therapeutics CMMB Stock Holding History

XTX Topco’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.2K Sell
18,629
-384
-2% -$656 ﹤0.01% 3461
2025
Q4 		$31.4K Buy
+19,013
New +$50.4K ﹤0.01% 2955
2025
Q2 		– Sell
-3,319
Closed -$14.5K – 2462
2025
Q1 		$14.5K Sell
3,319
-2,913
-47% -$20.4K ﹤0.01% 2200
2024
Q4 		$45.1K Buy
6,232
+2,426
+64% +$15.3K ﹤0.01% 1915
2024
Q3 		$23.9K Buy
3,806
+39
+1% +$219 ﹤0.01% 1808
2024
Q2 		$13.9K Buy
+3,767
New +$13K ﹤0.01% 1659
2024
Q1 		– Sell
-7,262
Closed -$14.8K – 1897
2023
Q4 		$14.8K Buy
+7,262
New +$19.1K ﹤0.01% 1392

Other funds holding CMMB

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PIP
Philadelphia Investment Partners Voorhees, New Jersey $147M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

XTX Topco's CMMB Position: Q1 2026 in Review

XTX Topco reduced its Chemomab Therapeutics (CMMB) stake by 2% in Q1 2026, selling an estimated $656 and leaving 18,629 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3461.

XTX Topco first reported a position in CMMB in Q4 2023 and has held it in 7 quarters since. The position peaked at $45.1K in Q4 2024. 15 funds tracked by Wall St. Rank hold CMMB as of Q1 2026.

  • XTX Topco held 18,629 shares of Chemomab Therapeutics worth $29.2K as of Q1 2026.
  • XTX Topco sold 384 Chemomab Therapeutics shares in Q1 2026, an estimated $656.
  • Chemomab Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3461 holding.
  • XTX Topco first reported a position in Chemomab Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • XTX Topco's Chemomab Therapeutics position peaked at $45.1K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.